 | • レポートコード：QAF27550 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のアルツハイマー病治療薬市場について種類別（ドネペジル、メマンチン、リバスチグミン）、用途別（初期-中期段階、中期-重度段階）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アルツハイマー病治療薬市場の概要 ・世界の主要地域別アルツハイマー病治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のアルツハイマー病治療薬市場規模2016-2021：種類別（ドネペジル、メマンチン、リバスチグミン） ・世界のアルツハイマー病治療薬市場予測2012-2027：種類別（ドネペジル、メマンチン、リバスチグミン） ・世界のアルツハイマー病治療薬市場規模2016-2021：用途別（初期-中期段階、中期-重度段階） ・世界のアルツハイマー病治療薬市場予測2012-2027：用途別（初期-中期段階、中期-重度段階） ・アルツハイマー病治療薬のアメリカ市場規模と予測2016-2021 ・アルツハイマー病治療薬のヨーロッパ市場規模と予測2016-2021 ・アルツハイマー病治療薬の中国市場規模と予測2016-2021 ・アルツハイマー病治療薬の日本市場規模と予測2016-2021 ・アルツハイマー病治療薬の東南アジア市場規模と予測2016-2021 ・アルツハイマー病治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck） ・アルツハイマー病治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アルツハイマー病治療薬の市場動向・機会・課題 ・調査の結論 |
Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer’s disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.The classification of alzheimer’s disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.
Market Analysis and Insights: Global Alzheimer’s Disease Drug Market
The global Alzheimer’s Disease Drug market was valued at US$ 1764.1 in 2020 and will reach US$ 876.7 million by the end of 2027, growing at a CAGR of -11.0% during 2022-2027.
Global Alzheimer’s Disease Drug Scope and Market Size
The global Alzheimer’s Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Donepezil
Memantine
Rivastigmine
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
The Alzheimer’s Disease Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Alzheimer’s Disease Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
1 Alzheimer’s Disease Drug Market Overview
1.1 Alzheimer’s Disease Drug Product Scope
1.2 Alzheimer’s Disease Drug Segment by Type
1.2.1 Global Alzheimer’s Disease Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Alzheimer’s Disease Drug Segment by Application
1.3.1 Global Alzheimer’s Disease Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Alzheimer’s Disease Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Alzheimer’s Disease Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Alzheimer’s Disease Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Alzheimer’s Disease Drug Price Trends (2016-2027)
2 Alzheimer’s Disease Drug Estimates and Forecasts by Region
2.1 Global Alzheimer’s Disease Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Alzheimer’s Disease Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Alzheimer’s Disease Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Alzheimer’s Disease Drug Revenue Market Share by Region (2016-2021)
2.3 Global Alzheimer’s Disease Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Alzheimer’s Disease Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Alzheimer’s Disease Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Alzheimer’s Disease Drug Estimates and Projections (2016-2027)
2.4.2 Europe Alzheimer’s Disease Drug Estimates and Projections (2016-2027)
2.4.3 China Alzheimer’s Disease Drug Estimates and Projections (2016-2027)
2.4.4 Japan Alzheimer’s Disease Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Alzheimer’s Disease Drug Estimates and Projections (2016-2027)
2.4.6 India Alzheimer’s Disease Drug Estimates and Projections (2016-2027)
3 Global Alzheimer’s Disease Drug Competition Landscape by Players
3.1 Global Top Alzheimer’s Disease Drug Players by Sales (2016-2021)
3.2 Global Top Alzheimer’s Disease Drug Players by Revenue (2016-2021)
3.3 Global Alzheimer’s Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer’s Disease Drug as of 2020)
3.4 Global Alzheimer’s Disease Drug Average Price by Company (2016-2021)
3.5 Manufacturers Alzheimer’s Disease Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Alzheimer’s Disease Drug Market Size by Type
4.1 Global Alzheimer’s Disease Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Alzheimer’s Disease Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Alzheimer’s Disease Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Alzheimer’s Disease Drug Price by Type (2016-2021)
4.2 Global Alzheimer’s Disease Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Alzheimer’s Disease Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Alzheimer’s Disease Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Alzheimer’s Disease Drug Price Forecast by Type (2022-2027)
5 Global Alzheimer’s Disease Drug Market Size by Application
5.1 Global Alzheimer’s Disease Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Alzheimer’s Disease Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Alzheimer’s Disease Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Alzheimer’s Disease Drug Price by Application (2016-2021)
5.2 Global Alzheimer’s Disease Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Alzheimer’s Disease Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Alzheimer’s Disease Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Alzheimer’s Disease Drug Price Forecast by Application (2022-2027)
6 North America Alzheimer’s Disease Drug Market Facts & Figures
6.1 North America Alzheimer’s Disease Drug Sales by Company
6.1.1 North America Alzheimer’s Disease Drug Sales by Company (2016-2021)
6.1.2 North America Alzheimer’s Disease Drug Revenue by Company (2016-2021)
6.2 North America Alzheimer’s Disease Drug Sales Breakdown by Type
6.2.1 North America Alzheimer’s Disease Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Alzheimer’s Disease Drug Sales Breakdown by Type (2022-2027)
6.3 North America Alzheimer’s Disease Drug Sales Breakdown by Application
6.3.1 North America Alzheimer’s Disease Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Alzheimer’s Disease Drug Sales Breakdown by Application (2022-2027)
7 Europe Alzheimer’s Disease Drug Market Facts & Figures
7.1 Europe Alzheimer’s Disease Drug Sales by Company
7.1.1 Europe Alzheimer’s Disease Drug Sales by Company (2016-2021)
7.1.2 Europe Alzheimer’s Disease Drug Revenue by Company (2016-2021)
7.2 Europe Alzheimer’s Disease Drug Sales Breakdown by Type
7.2.1 Europe Alzheimer’s Disease Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Alzheimer’s Disease Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Alzheimer’s Disease Drug Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)
8 China Alzheimer’s Disease Drug Market Facts & Figures
8.1 China Alzheimer’s Disease Drug Sales by Company
8.1.1 China Alzheimer’s Disease Drug Sales by Company (2016-2021)
8.1.2 China Alzheimer’s Disease Drug Revenue by Company (2016-2021)
8.2 China Alzheimer’s Disease Drug Sales Breakdown by Type
8.2.1 China Alzheimer’s Disease Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Alzheimer’s Disease Drug Sales Breakdown by Type (2022-2027)
8.3 China Alzheimer’s Disease Drug Sales Breakdown by Application
8.3.1 China 248 Sales Breakdown by Application (2016-2021)
8.3.2 China 248 Sales Breakdown by Application (2022-2027)
9 Japan Alzheimer’s Disease Drug Market Facts & Figures
9.1 Japan Alzheimer’s Disease Drug Sales by Company
9.1.1 Japan Alzheimer’s Disease Drug Sales by Company (2016-2021)
9.1.2 Japan Alzheimer’s Disease Drug Revenue by Company (2016-2021)
9.2 Japan Alzheimer’s Disease Drug Sales Breakdown by Type
9.2.1 Japan Alzheimer’s Disease Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Alzheimer’s Disease Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Alzheimer’s Disease Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Alzheimer’s Disease Drug Market Facts & Figures
10.1 Southeast Asia Alzheimer’s Disease Drug Sales by Company
10.1.1 Southeast Asia Alzheimer’s Disease Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Alzheimer’s Disease Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Alzheimer’s Disease Drug Sales Breakdown by Type
10.2.1 Southeast Asia Alzheimer’s Disease Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Alzheimer’s Disease Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Alzheimer’s Disease Drug Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Alzheimer’s Disease Drug Market Facts & Figures
11.1 India Alzheimer’s Disease Drug Sales by Company
11.1.1 India Alzheimer’s Disease Drug Sales by Company (2016-2021)
11.1.2 India Alzheimer’s Disease Drug Revenue by Company (2016-2021)
11.2 India Alzheimer’s Disease Drug Sales Breakdown by Type
11.2.1 India Alzheimer’s Disease Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Alzheimer’s Disease Drug Sales Breakdown by Type (2022-2027)
11.3 India Alzheimer’s Disease Drug Sales Breakdown by Application
11.3.1 India Alzheimer’s Disease Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Alzheimer’s Disease Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Alzheimer’s Disease Drug Business
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Business Overview
12.1.3 Allergan Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Alzheimer’s Disease Drug Products Offered
12.1.5 Allergan Recent Development
12.2 Eisai
12.2.1 Eisai Corporation Information
12.2.2 Eisai Business Overview
12.2.3 Eisai Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eisai Alzheimer’s Disease Drug Products Offered
12.2.5 Eisai Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Alzheimer’s Disease Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Daiichi Sankyo
12.4.1 Daiichi Sankyo Corporation Information
12.4.2 Daiichi Sankyo Business Overview
12.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Daiichi Sankyo Alzheimer’s Disease Drug Products Offered
12.4.5 Daiichi Sankyo Recent Development
12.5 Merz Pharma
12.5.1 Merz Pharma Corporation Information
12.5.2 Merz Pharma Business Overview
12.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merz Pharma Alzheimer’s Disease Drug Products Offered
12.5.5 Merz Pharma Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Alzheimer’s Disease Drug Products Offered
12.6.5 Pfizer Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Corporation Information
12.7.2 Johnson & Johnson Business Overview
12.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Johnson & Johnson Alzheimer’s Disease Drug Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 Lundbeck
12.8.1 Lundbeck Corporation Information
12.8.2 Lundbeck Business Overview
12.8.3 Lundbeck Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lundbeck Alzheimer’s Disease Drug Products Offered
12.8.5 Lundbeck Recent Development
13 Alzheimer’s Disease Drug Manufacturing Cost Analysis
13.1 Alzheimer’s Disease Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Alzheimer’s Disease Drug
13.4 Alzheimer’s Disease Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Alzheimer’s Disease Drug Distributors List
14.3 Alzheimer’s Disease Drug Customers
15 Market Dynamics
15.1 Alzheimer’s Disease Drug Market Trends
15.2 Alzheimer’s Disease Drug Drivers
15.3 Alzheimer’s Disease Drug Market Challenges
15.4 Alzheimer’s Disease Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Alzheimer's Disease Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Alzheimer's Disease Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Alzheimer's Disease Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Alzheimer's Disease Drug Sales (M Units) by Region (2016-2021)
Table 5. Global Alzheimer's Disease Drug Sales Market Share by Region (2016-2021)
Table 6. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Alzheimer's Disease Drug Revenue Share by Region (2016-2021)
Table 8. Global Alzheimer's Disease Drug Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Alzheimer's Disease Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Alzheimer's Disease Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Alzheimer's Disease Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Alzheimer's Disease Drug Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Alzheimer's Disease Drug Sales Share by Company (2016-2021)
Table 14. Global Alzheimer's Disease Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Alzheimer's Disease Drug Revenue Share by Company (2016-2021)
Table 16. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Drug as of 2020)
Table 17. Global Alzheimer's Disease Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Alzheimer's Disease Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Alzheimer's Disease Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Alzheimer's Disease Drug Sales (M Units) by Type (2016-2021)
Table 22. Global Alzheimer's Disease Drug Sales Share by Type (2016-2021)
Table 23. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Alzheimer's Disease Drug Sales Share by Type (2022-2027)
Table 26. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Alzheimer's Disease Drug Revenue Share by Type (2022-2027)
Table 28. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Alzheimer's Disease Drug Sales (M Units) by Application (2016-2021)
Table 30. Global Alzheimer's Disease Drug Sales Share by Application (2016-2021)
Table 31. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Alzheimer's Disease Drug Sales (M Units) by Application (2022-2027)
Table 34. Global Alzheimer's Disease Drug Sales Share by Application (2022-2027)
Table 35. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Alzheimer's Disease Drug Revenue Share by Application (2022-2027)
Table 37. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Alzheimer's Disease Drug Sales (M Units) by Company (2016-2021)
Table 39. North America Alzheimer's Disease Drug Sales Market Share by Company (2016-2021)
Table 40. North America Alzheimer's Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Alzheimer's Disease Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 43. North America Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Table 44. North America Alzheimer's Disease Drug Sales by Type (2022-2027) & (M Units)
Table 45. North America Alzheimer's Disease Drug Sales Market Share by Type (2022-2027)
Table 46. North America Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 47. North America Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Table 48. North America Alzheimer's Disease Drug Sales by Application (2022-2027) & (M Units)
Table 49. North America Alzheimer's Disease Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Alzheimer's Disease Drug Sales (M Units) by Company (2016-2021)
Table 51. Europe Alzheimer's Disease Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Alzheimer's Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Alzheimer's Disease Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 55. Europe Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Alzheimer's Disease Drug Sales by Type (2022-2027) & (M Units)
Table 57. Europe Alzheimer's Disease Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 59. Europe Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Alzheimer's Disease Drug Sales by Application (2022-2027) & (M Units)
Table 61. Europe Alzheimer's Disease Drug Sales Market Share by Application (2022-2027)
Table 62. China Alzheimer's Disease Drug Sales (M Units) by Company (2016-2021)
Table 63. China Alzheimer's Disease Drug Sales Market Share by Company (2016-2021)
Table 64. China Alzheimer's Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Alzheimer's Disease Drug Revenue Market Share by Company (2016-2021)
Table 66. China Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 67. China Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Table 68. China Alzheimer's Disease Drug Sales by Type (2022-2027) & (M Units)
Table 69. China Alzheimer's Disease Drug Sales Market Share by Type (2022-2027)
Table 70. China Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 71. China Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Table 72. China Alzheimer's Disease Drug Sales by Application (2022-2027) & (M Units)
Table 73. China Alzheimer's Disease Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Alzheimer's Disease Drug Sales (M Units) by Company (2016-2021)
Table 75. Japan Alzheimer's Disease Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Alzheimer's Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Alzheimer's Disease Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 79. Japan Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Alzheimer's Disease Drug Sales by Type (2022-2027) & (M Units)
Table 81. Japan Alzheimer's Disease Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 83. Japan Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Alzheimer's Disease Drug Sales by Application (2022-2027) & (M Units)
Table 85. Japan Alzheimer's Disease Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Alzheimer's Disease Drug Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Alzheimer's Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Alzheimer's Disease Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Alzheimer's Disease Drug Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Alzheimer's Disease Drug Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Application (2022-2027)
Table 98. India Alzheimer's Disease Drug Sales (M Units) by Company (2016-2021)
Table 99. India Alzheimer's Disease Drug Sales Market Share by Company (2016-2021)
Table 100. India Alzheimer's Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Alzheimer's Disease Drug Revenue Market Share by Company (2016-2021)
Table 102. India Alzheimer's Disease Drug Sales by Type (2016-2021) & (M Units)
Table 103. India Alzheimer's Disease Drug Sales Market Share by Type (2016-2021)
Table 104. India Alzheimer's Disease Drug Sales by Type (2022-2027) & (M Units)
Table 105. India Alzheimer's Disease Drug Sales Market Share by Type (2022-2027)
Table 106. India Alzheimer's Disease Drug Sales by Application (2016-2021) & (M Units)
Table 107. India Alzheimer's Disease Drug Sales Market Share by Application (2016-2021)
Table 108. India Alzheimer's Disease Drug Sales by Application (2022-2027) & (M Units)
Table 109. India Alzheimer's Disease Drug Sales Market Share by Application (2022-2027)
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Business Overview
Table 112. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Allergan Alzheimer's Disease Drug Product
Table 114. Allergan Recent Development
Table 115. Eisai Corporation Information
Table 116. Eisai Description and Business Overview
Table 117. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Eisai Alzheimer's Disease Drug Product
Table 119. Eisai Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Alzheimer's Disease Drug Product
Table 124. Novartis Recent Development
Table 125. Daiichi Sankyo Corporation Information
Table 126. Daiichi Sankyo Description and Business Overview
Table 127. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Daiichi Sankyo Alzheimer's Disease Drug Product
Table 129. Daiichi Sankyo Recent Development
Table 130. Merz Pharma Corporation Information
Table 131. Merz Pharma Description and Business Overview
Table 132. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Merz Pharma Alzheimer's Disease Drug Product
Table 134. Merz Pharma Recent Development
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Pfizer Alzheimer's Disease Drug Product
Table 139. Pfizer Recent Development
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Business Overview
Table 142. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Johnson & Johnson Alzheimer's Disease Drug Product
Table 144. Johnson & Johnson Recent Development
Table 145. Lundbeck Corporation Information
Table 146. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Lundbeck Description and Business Overview
Table 148. Lundbeck Alzheimer's Disease Drug Product
Table 149. Lundbeck Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Alzheimer's Disease Drug Distributors List
Table 153. Alzheimer's Disease Drug Customers List
Table 154. Alzheimer's Disease Drug Market Trends
Table 155. Alzheimer's Disease Drug Market Drivers
Table 156. Alzheimer's Disease Drug Market Challenges
Table 157. Alzheimer's Disease Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer's Disease Drug Product Picture
Figure 2. Global Alzheimer's Disease Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Alzheimer's Disease Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Early to Moderate Stages Examples
Figure 7. Moderate to Severe Stages Examples
Figure 8. Global Alzheimer's Disease Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Alzheimer's Disease Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Alzheimer's Disease Drug Sales (M Units) Growth Rate (2016-2027)
Figure 11. Global Alzheimer's Disease Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Alzheimer's Disease Drug Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Alzheimer's Disease Drug Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Alzheimer's Disease Drug Sales (M Units) Growth Rate (2016-2027)
Figure 16. Europe Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Alzheimer's Disease Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Alzheimer's Disease Drug Players Market Share by Revenue in Alzheimer's Disease Drug: 2016 & 2020
Figure 27. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Alzheimer's Disease Drug Revenue Share by Type (2016-2021)
Figure 29. Global Alzheimer's Disease Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Alzheimer's Disease Drug Revenue Share by Application (2016-2021)
Figure 31. Global Alzheimer's Disease Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Alzheimer's Disease Drug Sales Market Share by Type in 2020
Figure 33. North America Alzheimer's Disease Drug Sales Market Share by Application in 2020
Figure 34. Europe Alzheimer's Disease Drug Sales Market Share by Type in 2020
Figure 35. Europe Alzheimer's Disease Drug Sales Market Share by Application in 2020
Figure 36. China Alzheimer's Disease Drug Sales Market Share by Type in 2020
Figure 37. China Alzheimer's Disease Drug Sales Market Share by Application in 2020
Figure 38. Japan Alzheimer's Disease Drug Sales Market Share by Type in 2020
Figure 39. Japan Alzheimer's Disease Drug Sales Market Share by Application in 2020
Figure 40. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Type in 2020
Figure 41. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Application in 2020
Figure 42. India Alzheimer's Disease Drug Sales Market Share by Type in 2020
Figure 43. India Alzheimer's Disease Drug Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Alzheimer's Disease Drug
Figure 46. Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure 47. Alzheimer's Disease Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の認知症＆アルツハイマー病治療市場規模・現状・予測（2021年-2027年） Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily lives of patients. Market Analysis and Insights: Global Dementia and Alzheimer’s Disease Treatment Mark…- 世界のアルツハイマー病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alzheimer Disease Treatment Market The global Alzheimer Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Meniere Disease Drug Pipeline Market The global Meniere Disease Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界の自己免疫疾患治療薬市場規模・現状・予測（2021年-2027年） Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well …
- 世界のバッテン病治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Batten Disease Drug Pipeline Market The global Batten Disease Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…